Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 May 31;6(4):327-328.
doi: 10.1016/j.ijwd.2020.05.014. eCollection 2020 Sep.

Work impairment in a woman with severe hidradenitis suppurativa after delayed diagnosis: A call for action

Monica Shah  1 , Muskaan Sachdeva  1 , Afsaneh Alavi  2   3   4
Affiliations
Case Reports

Work impairment in a woman with severe hidradenitis suppurativa after delayed diagnosis: A call for action

Monica Shah et al. Int J Womens Dermatol. .

Erratum in

  • Erratum regarding previously published articles.
    [No authors listed] [No authors listed] Int J Womens Dermatol. 2021 Sep 28;7(5Part B):868. doi: 10.1016/j.ijwd.2021.09.012. eCollection 2021 Dec. Int J Womens Dermatol. 2021. PMID: 35028406 Free PMC article.
No abstract available

Keywords: Diagnostic delay; Hidradenitis suppurativa; Treatment; Work absenteeism; Work impairment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Severe interconnected sinus tracts of the axilla, consistent with Hurley stage III.
See this image and copyright information in PMC

References

    1. Clerc H., Tavernier E., Giraudeau B., Bourdais-Sallot A., Samimi M., Abdo I. Understanding the long diagnostic delay for hidradenitis suppurativa: a national survey among French general practicioners. Eur J Dermatol. 2019;29:97–99. - PubMed
    1. Garg A., Neuren E., Cha D., Kirby J.S., Ingram J.R., Jemec G.B.E. Evaluating patients’ unmet needs in hidradenitis suppurativa: Results from the Global Survey of Impact and Healthcare Needs (VOICE) Project. J Am Acad Dermatol. 2020;82(2):366–376. - PubMed
    1. Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, et al. Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study. Br J Dermatol 2020 [Epub ahead of print]. - PubMed
    1. Sandhu V., Shah M., Piguet V., Alavi A. The impact of hidradenitis suppurativa on work productivity and activity impairment. Br J Dermatol. 2020;182(5):1288–1290. - PubMed
    1. Zimman S., Comparatore M.V., Vulcano A.F., Absi M.L., Mazzuoccolo L.D. Hidradenitis suppurativa: Estimated prevalence, clinical features, concomitant conditions, and diagnostic delay in a university teaching hospital in Buenos Aires, Argentina. Actas Dermosifiliogr. 2019;110(4):297–302. - PubMed

Publication types